Reexamining remission definitions in rheumatoid arthritis: considering the Twenty-Eight-Joint Disease Activity Score, C-reactive protein level, and patient global assessment: comment on the article by Felson et al

被引：0

作者：

Ferreira, Ricardo J. O. ^{[1
,2
]}

Welsing, Paco M. J. ^{[3
]}

Jacobs, Johannes W. G. ^{[3
]}

Gossec, Laure ^{[4
,5
]}

Ndosi, Mwidimi ^{[6
]}

Machado, Pedro M. ^{[7
,8
]}

van der Heijde, Desiree ^{[9
]}

da Silva, Jose A. P. ^{[1
,10
]}

机构：

[1] Ctr Hosp & Univ Coimbra, Coimbra, Portugal

[2] Nursing Sch Coimbra, Coimbra, Portugal

[3] Univ Med Ctr, Utrecht, Netherlands

[4] Sorbonne Univ, INSERM, Paris, France

[5] Hop La Pitie Salpetriere, AP HP, Paris, France

[6] Univ West England, Bristol, Avon, England

[7] UCL, Univ Coll London Hosp NHS Fdn Trust, London, England

[8] London North West Univ Healthcare NHS Trust, Northwick Pk Hosp, London, England

[9] Leiden Univ Med Ctr, Leiden, Netherlands

[10] Univ Coimbra, Coimbra, Portugal

来源：

ARTHRITIS CARE & RESEARCH | 2022年 / 74卷 / 03期

关键词：

CLINICAL-PRACTICE;

D O I：

10.1002/acr.24843

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：501 / 502

页数：2

共 25 条

[21] Limited value of the multi-biomarker disease activity assay compared to the Routine Assessment of Patient Index Data 3 (RAPID3) score in the prognosis of important clinical outcomes in rheumatoid arthritis: comment on the article by Fleischmann et al and accompanying editorial by Davis
Pincus, Theodore
Block, Joel A.
Yazici, Yusuf
Bergman, Martin J.
Sokka, Tuulikki
ARTHRITIS & RHEUMATOLOGY, 2017, 69 (04) : 866 - 867
[22] Limited value of the multi-biomarker disease activity assay compared to the Routine Assessment of Patient Index Data 3 (RAPID3) score in the prognosis of important clinical outcomes in rheumatoid arthritis: comment on the article by Fleischmann et al and accompanying editorial by Davis Reply
Fleischmann, Roy
Connolly, Sean E.
Maldonado, Michael A.
Schiff, Michael
ARTHRITIS & RHEUMATOLOGY, 2017, 69 (04) : 867 - 868
[23] Predictors of Significant Disease Activity Score-28 (Using C-reactive protein) Remission Achieved with Intravenous Golimumab in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of the Phase 3, Multicenter, Double-Blind, Placebo-Controlled Trial
Bingham, Clifton O., III
Weinblatt, Michael
Mendelsohn, Alan
Kim, Lilianne
Mack, Michael
Lu, Jiandong
Baker, Daniel
Westhovens, Rene
ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S558 - S558
[24] PREDICTORS OF SIGNIFICANT DISEASE ACTIVITY SCORE-28 (USING C-REACTIVE PROTEIN) REMISSION ACHIEVED WITH INTRAVENOUS GOLIMUMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY: RESULTS OF THE PHASE III, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Bingham, Clifton O.
Weinblatt, Michael E.
Mendelsohn, Alan
Kim, Lilianne
Mack, Michael
Lu, Jiandong
Baker, Daniel
Westhovens, Rene
RHEUMATOLOGY, 2013, 52 : 82 - 83
[25] Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate
Wells, G.
Becker, J-C
Teng, J.
Dougados, M.
Schiff, M.
Smolen, J.
Aletaha, D.
van Riel, P. L. C. M.
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (06) : 954 - 960

← 1 2 3 →